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Treating Low NIHSS Strokes
Ahmad-Riad Ramadan, MD
Division of Vascular Neurology
Division of Neurocritical Care
Department of Neurology
Henry Ford Hospital

Before we begin

This presentation will focus on the treatment of nondisabling or “minor” strokes, which frequently poses a
clinical dilemma

On the menu
●
●
●
●

Definition, prevalence and prognosis of low NIHSS strokes (LNS)
How can we predict deterioration of minor strokes?
Intravenous thrombolysis in LNS
Mechanical thrombectomy in LNS
○ Proximal occlusions
○ Distal occlusions

disabling strokes

minor strokes

Why are lNS worth talking about?
● Any stroke type can present with minor symptoms initially
● Minor LVO strokes can quickly become severe and disabling
○ Expansion of clot
○ Complete vessel occlusion
○ Failure of collaterals
○ Hemodynamic compromise, reduction in oxygen carrying capacity of blood
● Many times, acute intervention is foregone because the thought is that risks
outweigh benefits
● We need better patient selection and prediction tools to understand which patients
will deteriorate and therefore needs emergent therapy

A unique and challenging population
● Difficult identification
○ What is considered a LNS? <10? <6? <4?
○ NIHSS is imperfect
● Difficult researchability
○ Low prevalence and incidence
○ Slow enrollment
○ Heterogeneity in identification of LNS
● Difficult predictability
○ Unpredictable course, potential for worsening/deterioration
○ Particularly true for LVO

Epidemiology of LNS
● Get With The Guidelines (GWTG)–Stroke registry 1
○ 33,995 patients
○ 22.4% had an NIHSS score < 6
● Safe Implementation of Treatment in Stroke (SITS) registry 2
○ 24.9% of patients with NIHSS scores < 6 had a LVO
● In one study 3, of 29 patients who had LVO and a favorable penumbra but were not
deemed eligible for MT, 5 (16%) were not considered because of mild symptoms
1 Romano,

et al. JAMA Neurol. 2015;72:423-431
et al. Eur Stroke J. 2018;3:29-38
3 Hosseini, et al. J Neuroimaging. 2018 Nov;28(6):676-682
2 Mazya,

Challenging population to research
● We don’t have the numbers!
○ For mechanical thrombectomy
■ No available RCT on LNS with LVO
■ Of the 5 landmark MT trials, only MR CLEAN included patients with NIHSS <6
○ For IV thrombolysis
■ The main RCT available, PRISMS, was underpowered and stopped enrolling
prematurely
● Wide variability in definition of low NIHSS across studies
○ NIHSS threshold anywhere between 3 and 10
○ Variable distribution of occlusion sites in LVO cases across studies

Natural course of LNS
● Presence of a symptomatic arterial occlusion is strongest independent predictor of
early neurologic deterioration
○ In one study 1, untreated LVO were 2x more likely to expand stroke
(OR= 2.206; 95% CI, 1.219–3.994; P = .009)
○ In another study 2, untreated proximal LVO (M1/ICA) were 7x more likely to
have poor outcome (OR= 7.13; 95% CI, 1.1–45.5; P < .038)
● Unfavorable prognosis of untreated LNS with LVO
○ In one study 3, 22.7% of patients deteriorated within 24 hours, 33.3% during
hospital stay, and 41.4% within 3 months. Mortality rate = 6.7%.
1 Kim, et al. PLoS One. 2013;8:e70996
○ Stats echoed in other studies
2
3 Heldner,

Nedeltchev, et al. Stroke. 2007;38:2531-2535
et al. J Neurol Neurosurg Psychiatry. 2015;86:755-760

Predictors of deterioration
●
●
●
●

Large vessel occlusion, proximal > distal
Collateral quality, cerebral reserve
Hemodynamic status
Nature of occlusion? atherosclerotic stenosis vs embolism?

Hosseini, et al. J Neuroimaging. 2018 Nov;28(6):676-682

Intravenous thrombolysis in LNS

Khatri, et al. JAMA. 2018;320(2):156-166

Khatri, et al. JAMA. 2018;320(2):156-166

Intravenous thrombolysis in LNS
● Criticisms/limitations
○ Trial terminated early due to slow enrollment by sponsor. Only 313 of the
intended 1000 subjects were enrolled
○ Unknown proportion of patients with LVO
■ Important info because IV tPA is not as efficient at recanalizing a LVO,
especially the longer the thrombus is (recent Stroke study: cutoff 9 mm)
○ Stroke mimics were included
● Conclusion from PRISMS
○ Severe limitations prevent from drawing definitive conclusions
○ Cannot reliably recommend IV tPA for non-disabling LNS at this point

BRIDGING THERAPY in LNS
● Tenecteplase (TNK) gaining momentum as thrombolytic therapy
○ Advantages of TNK: ↑ half-life, ↑ fibrin-specificity and ↑ resistance to PAI
than alteplase
○ In EXTEND-IA TNK 1, TNK achieved higher recanalization at initial angiogram
and better functional outcomes at 90 days compared with alteplase
● TNK is being investigated as bridging therapy (thrombolysis followed by
thrombectomy) in LNS with LVO in TEMPO-2
○ NIHSS <5 presenting within 12 hours of onset of symptoms with proven
occlusion
○ TEMPO 1 demonstrated safety and feasibility
1 Campbell,

et al. N Engl J Med 2018; 378:1573-1582

Mechanical thrombectomy in LNS
● No RCT available to guide management
● Only retrospective observational studies and case series with wide variability in
methods, inclusion criteria and treatment times
● Many studies have shown benefit or signal towards benefit for MT

93% vs 69.2%; P = 0.04

Haussen Dc, et al. J NeuroIntervent Surg 2018;10:325–329

Griessenauer CJ, et al. World Neurosurg. 2018;110:263-269

MT in LNS by thrombus location (90d functional outcome)

All

ICA
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M2

Sarraj, et al. Stroke. 2018;49:2398-2405

MT in LNS by thrombus location (90d functional outcome)

Proximal
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Distal
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ACA)

Sarraj, et al. Stroke. 2018;49:2398-2405

MT in LNS by thrombus location (90d functional outcome)

Sarraj, et al. Stroke. 2018;49:2398-2405

Proposed
Algorithm

Take home messages (1)
● Strokes presenting initially with minor deficits may worsen and lead to long-term
disability
● Be aware of factors that can lead to neurological deterioration of a minor stroke,
e.g. LVO (proximal), poor collateral circulation
● Heterogeneity/variability in definition of minor strokes and slow enrollment have
made it difficult to research this subpopulation
● We are in desperate need of large RCTs to guide adequate treatment in this group

Take home messages (2)
● IV thrombolysis alone may not be the best therapy for minor stroke
● MT+IV tPA may have a role for minor strokes with LVO
● MT may be beneficial in minor strokes with proximal but not distal LVO
● Use of perfusion imaging and collateral scoring may help select patients who will
benefit from acute therapies

Thank you

